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Abstract
Detection of interacting risk factors for complex traits is challenging. The choice of an appropriate method, sample size, and
allocation of cases and controls are serious concerns. To provide empirical guidelines for planning such studies and data
analyses, we investigated the performance of the multifactor dimensionality reduction (MDR) and generalized MDR (GMDR)
methods under various experimental scenarios. We developed the mathematical expectation of accuracy and used it as an
indicator parameter to perform a gene-gene interaction study. We then examined the statistical power of GMDR and MDR
within the plausible range of accuracy (0.50,0.65) reported in the literature. The GMDR with covariate adjustment had a
power of.80% in a case-control design with a sample size of$2000, with theoretical accuracy ranging from 0.56 to 0.62.
However, when the accuracy was,0.56, a sample size of$4000 was required to have sufficient power. In our simulations,
the GMDR outperformed the MDR under all models with accuracy ranging from 0.56,0.62 for a sample size of 1000–2000.
However, the two methods performed similarly when the accuracy was outside this range or the sample was significantly
larger. We conclude that with adjustment of a covariate, GMDR performs better than MDR and a sample size of 1000,2000
is reasonably large for detecting gene-gene interactions in the range of effect size reported by the current literature;
whereas larger sample size is required for more subtle interactions with accuracy,0.56.
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Introduction
Complex traits are controlled by multiple genetic factors working
in concert and responding to the environment. Although the exact
inheritance mechanisms of such traits are largely unknown, it is
commonly accepted that there are interactions of numerous
biological processes, which contribute, directly or indirectly, to
phenotypes [1,2]. These genetic mechanisms differ from those of
conventional Mendelian traits in several ways: (1) multiple genes are
involved [3,4]; (2) the roles of the genes are defined in the context of
their related genes;and (3) the magnitude of the gene effectsdepends
on the environment to which they are exposed [5]. A major
achievement in detecting epistasis for complex traits is the
development of constructive induction approaches [6], including
the multifactor dimensionality reduction method (MDR) [7,8,9], the
combinatorial partitioning method (CPM) [10], and the restricted
partition method (RPM) [11]. The MDR is a powerful approach to
detect gene-gene (G6G) interactions and ideally discriminates
between discrete clinical endpoints when using multilocus genotypes
[12]. To circumvent the weaknesses of existing MDR approaches
[13], we previously developed a generalized MDR (GMDR)
statistical framework applicable to both dichotomous and quantita-
tive phenotypes that allows adjustment for covariates in population-
based study designs [14]. We then extended our approach to family-
based designs with pedigree-based GMDR (PGMDR) [15], and
other extensions of it are emerging [16,17,18]. So far, MDR and its
extensions have identified many interacting genetic variants
underlying various complex human diseases, such as Alzheimer
disease [19], asthma [20], atrial fibrillation [21], autism [22],
bladder cancer [23], hypertension [24], nicotine dependency
[14,15,25,26], prostate cancer [27,28], schizophrenia [29], sporadic
breast cancer [7], thrombotic stroke [30], and Type II diabetes
[31,32] (see Table S1 for details).
Statistical power is a key factor to consider when an investigator
designs a trial. Although there is a vast literature on power analysis
for single-factor approaches [33,34,35,36,37,38,39,40,41], fewer
studies have explored the statistical power of MDR and its
extended approaches to detect interactions. A thorough study of
power for interaction detection under various theoretical assump-
tions is thus warranted, as statistical power depends on the specific
experimental scenario defined by factors such as sample size,
significance level, penetrance, population prevalence, allele
frequencies, interaction orders, interaction patterns, and sampling
scheme, all of which are difficult to determine exactly and can be
evaluated only by simulations. To reflect the reality as much as
possible for gene-gene interaction studies, we assessed statistical
power through intensive simulations of hypothetical scenarios with
regard to the information in the literature.
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16981The primary purpose of this study was to examine the statistical
power for detecting G6G interactions in case-control designs
using GMDR and MDR approaches through simulating various
scenarios with the goal of providing empirical guidelines for
designing such studies. Although it is generally preferred to use the
traditional parameters such as heritability and genotype-relative-
risk (GRR) [42] to characterize experimental scenarios, we
propose using accuracy as an indicator parameter to capture the
characteristics of an ascertained population. We demonstrate that
accuracy is practically estimable and Testing Accuracy (TA)
converges to theoretical accuracy in a large sample. Furthermore,
we establish an empirical link between TA and heritability.
Materials and Methods
Methods
Although the MDR and GMDR methods, as well as the
underlying terminology, have been presented in the literature
[7,9,14], we offer a brief summary here to enable readers to follow
our presentation easily. In general, these methods share the same
framework [9] (Figure S1). In step one, the dataset is partitioned
randomly into C equal or nearly equal subdivisions. (We use
C~10 throughout this report.) One subdivision is used as the
testing set and the rest as the independent training set. In step two,
a subset of r discrete genetic or environmental factors is selected
from all R factors of interest. We have
R
r
  
combinations
exhaustively. In step three, the training set stretches into r-
dimensional space, and each genotyped subject is allocated to a
cell accordingly. The values of the score statistic can be summed in
each cell. Here, the GMDR differs from the MDR in which the
numbers of cases and controls are directly employed. Without
adjustment for covariates, the GMDR is reduced to MDR [14].
Each non-empty cell is then labeled as either high-risk, if the
average statistic value is not less than a preset threshold T, or low-
risk otherwise. In step four, an interaction model is created by
pooling high- and low-risk cells into distinct groups. Some fitness
measure is then assessed. Without loss of generality, here we used
accuracy (i.e., classification accuracy in step four and TA in step
six), although other appropriate measure can also be used.
Balanced accuracy may be a better alternative in unbalanced
data sets [43]. In step five, all other possible combinations of r
factors in the training set are examined, and the best r-factor
model with the maximum classification accuracy is recorded. In
step six, the best model from step five is evaluated for TA by the
testing set. There are C pairs of training-testing sets, so the above
procedure is repeated independently C times on the sets, and the
best models are ranked.
As both the MDR and the GMDR use classification accuracy to
identify the best model and TA to evaluate the goodness of fit, we
examine here the property of ‘accuracy’, which is defined as
TPzTN
TPzFPzTNzFN
where TP is true positive having a high-risk value in the high-risk
group, TN is true negative with a low-risk value in the low-risk
group, FP is false positive, and FN is false negative. When other
metrics are used such as sensitivity
TP
TPzFN
, specificity
TN
TNzFP
,
and balanced accuracy
1
2
(
TP
TPzFN
z
TN
TNzFP
), they can be
evaluated similarly. For an ascertained population, accuracy is a
better characteristic parameter than heritability or GRR because
even the same heritability or GRR can result in various genotype
distributions with different allele frequencies, prevalences, pene-
trances, and ascertainment schemes. Further, accuracy is a natural
measure for the contribution rate of genes of interest because we
do not intend to estimate heritability and GRR parameters in the
nonparametric MDR and GMDR approaches. In what follows,
we use the logistical model to elucidate accuracy through
constructing a conditional genotypic distribution and conditional
score distributions and then to calculate the mathematical
expectation of accuracy.
Logistic model for a dichotomous trait
For a complex trait, in addition to a functional genotypic
combination, environmental factors affect penetrance. We con-
struct a general penetrance function by considering genotypic and
covariate effects together. For a dichotomous phenotype, y,
affected subjects are coded y~1 and unaffected y~0. Assume
the dichotomous trait y has a Bernoulli distribution with the
probability p for a subject being affected; this situation can be
modeled with a generalized linear model:
L~azx(g)bzzc ð1Þ
where L is a logit link function, a is the intercept, x(g) is the coding
for genotype g, z is the coding for the covariate, and b and c are
the corresponding parameters, respectively. Given the ith subject,
the probability of being affected is:
pi~
exp(azx(gi)bzzic)
1zexp(azx(gi)bzzic)
ð2Þ
The GMDR is based on the use of the residual score of model
(1), defined as:
si~yi{^ p pi ð3Þ
where ^ p pi is estimated from Equation (2) where ^ a a and ^ c c are their
maximum likelihood estimates (MLE) in model (1) under the null
hypothesis H0: b~0.
Conditional genotype and score distributions
To derive the theoretical accuracy, we first focus on the
genotype distribution for a case-control sample. Consider the case
sample by repeated application of Bayes’ theorem; for genotype k,
we have:
P(kjA)~
P(Ajk)P(k)
P
i
P(Aji)P(i)
ð4Þ
where P(Ajk) is the probability of being affected for a given
genotype k, P(k) is the prior probability of genotype k in the
population from which the sample comes, and the denominator is
the sum of the numerator over all genotypes. By applying
Equation (4) to the control sample, for a given genotype k,w e
obtain P(kjU)~
P(Ujk)P(k)
P
i
P(Uji)P(i)
, whereP(Ujk) is the probability of
an unaffected subject and P(Ujk)~1{P(Ajk). Under the null
hypothesis, the penetrances are the same for all genotypes, and
Power of MDR and GMDR for Interaction Detection
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and control samples. In contrast, under the alternative hypothesis,
the value of P(Ajk) depends on genotype k. For complex traits, it
is likely that covariate(s) are involved in their etiologies, and thus
P(Ajk) is further determined by the environmental factor, say, z,
so that: P(Ajk,z)~
exp(azx(gi)bzzic)
1zexp(azx(gi)bzzic)
, as presented in
Equation (2). P(Ajk)~E(P(Ajk,z)), which is obtained by the
integral of the expression over variable z given its probability
density function f(z):
E(P(Ajk,z))~
ð
z
P(Ajk,z)f(z)dz: ð5Þ
To demonstrate the method, we offer the theoretical genotype
distribution for a checkerboard model scenario, as commonly
employed in this type of interaction study [14,44,45]. In the
following sections, we consider a penetrance function containing
only one covariate, but when necessary, it can easily be extended
by incorporating more covariates and other effects; e.g., gene 6
environment factors. We assume a balanced case-control design
with 2000 unrelated subjects, MAF=0.5, a~{5:30, b~2:5,
c~1, and a covariate Z*N(0,10). Under such assumptions, the
trait is expected to have a heritability of 0.043 (according to the
definition of Culverhouse et al. [44]), and there are two
differential risk genotypic groups with their expected penetrances
of 0.073 and 0.221 (0.005 and 0.057 if the covariate is excluded),
which can be calculated from Equation (5) through numerical
solution. After applying these equations, we obtain the expected
genotype distribution for the case-control sample, as presented in
Figure 1A (see Text S1 for details on calculating this distribution).
Such an approach of generating the conditional genotype
distribution is flexible and can be applied easily to other
scenarios. When no covariate is considered, as assumed in the
MDR approach [46], the genotype distribution becomes a
simpler form.
The sums of the affected and unaffected scores in genotypic cell
k can be calculated as:
sA
k ~P(kjA)|E(s)
A
k |Ncase
sU
k ~P(kjU)|E(s)
U
k |Ncontrol
(
ð6Þ
respectively, where N: is the number of the cases or the controls
and E(s)k denotes the expectations of the score of an affected or an
unaffected subject given genotype k. E(s)k can be computed,
respectively:
E(s)
A
k ~
Ð
z
(1{
exp(azzc)
1zexp(azzc))P(Ajk,z)f(z)dz
Ð
z
P(Ajk,z)f(z)dz
c~0
E(s)
A
k ~1{p,
and
E(s)
U
k ~
Ð
z
(0{
exp(azzc)
1zexp(azzc))P(Ujk,z)f(z)dz
Ð
z
P(Ujk,z)f(z)dz
c~0
E(s)
U
k ~0{p:
In the case without adjustment by the covariate (c~0), these
two equations can be simplified, where p is the prevalence of the
disease in the sample with its expectation
exp(a)
1zexp(a)
. Figures 1B
and 1C show the score distributions without and with covariant
adjustment, respectively (see Text S2 for details on calculating the
distributions illustrated in Figure 1C). Although only one covariate
was adjusted in the derivation of the score distribution, such
adjustment of the covariate is necessary and can be applied to
cases with more than one covariate.
Accuracy and Testing Accuracy
As defined, the TA always ranges from 0.5 to 1.0. For the
GMDR method with and without covariate adjustment, the
accuracies for the case shown in Figures 1B and 1C are 0.648 and
0.743, respectively. Indeed, as discussed previously [14], without
adjustment of covariates, the accuracy can be estimated directly
Figure 1. Conditional genotype and score distributions. (A): Conditional genotype distribution; (B): Conditional score distribution without
covariate adjustment; and (C): Conditional score distribution with covariate adjustment. The parameters used in our simulations under the balanced
case-control design are: N =2000, MAF=0.5, a=-5.30, b=2.5, c=1, and Z*N(0,10).
doi:10.1371/journal.pone.0016981.g001
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confirmed by the identical values of other statistics calculated
from the distribution in Figures 1A and 1B.
TA is commonly used in GMDR and MDR. Because it is
context-dependent, its mathematical expectation is difficult to
derive straightforwardly. Empirically, we show in Figure 2 that
when the sample size increases to infinity under a checkerboard
model, TA approaches accuracy, which is the theoretical upper
bound of TA. For the cases illustrated, TA closely converges to
accuracy with a sample size of 1000,2000. The upper limit of TA
can be attained when, in the testing set, each genotypic cell is
recognized correctly as high or low risk after the cell has been
classified correctly in the training set.
Simulations
As approximately 85% of detected interactions involved more
than one, but less than four genetic loci (Table S1), in this report,
we present only the results from three interaction models on the
basis of 10 diallelic loci: one digenic (i.e., two functional gene loci
involved), one trigenic (i.e., there functional loci involved), and one
tetragenic (i.e., four functional loci involved). For convenience of
notation, loci are denoted by different letters and the two alleles at
each locus by uppercase and lowercase; e.g., A and a for locus 1, B
and b for locus 2, etc. For the digenic model, the checkerboard,
which was commonly used in epistatic studies because of its weak
marginal effects, was employed [14,44,45]. As elucidated previ-
ously, accuracy can serve as an indicator statistic to guide
experimental design, so we relaxed the definition of the detailed
genetic architecture of high-order interaction and focused on the
TA a model can reach. For simplicity, we used models called the 3
uppercase letter model (3ULM), in which genotypes with 3
uppercase letters were set as high risk (e.g., AaBbCc, AABbcc,
AAbbCc), and the 4 uppercase-letter model (4ULM), in which
genotypes containing 4 uppercase letters were set as high risk for
tetragenic interaction.
We employed a balanced experimental design with three
moderate sample sizes (500, 1000, and 2000) and two large
samples (4000 and 10,000) because large samples have been more
prevalent in many recent reports [47,48,49]. To cover a broad
spectrum, we set three levels (0.10, 0.25, and 0.50) of minor allele
frequency (MAF) for interacting loci. Hardy-Weinberg and linkage
equilibria were assumed throughout the simulations.
Our simulated populations followed the penetrance function
defined in Equation (2) where a is the intercept with a value of -
5.30, xi is the predictor variable coding for G6G interaction, and
zi is the covariate with a normal distribution N(0,10). Our
simulated genotypic effects were b=1.0, 1.5, 2.0, and 2.5,
respectively, and c~1. We investigated three interaction models,
four levels of b, three levels of MAF, and five sample sizes. There
were 180 scenarios in total for our simulation study. For each
scenario, we simulated 200 replications in order to produce a
precise evaluation of statistical power.
To calculate statistical power, we needed to determine the
threshold for each scenario under GMDR and MDR, respectively.
For GMDR, we shuffled the residual scores to generate pseudo-
samples under the null hypothesis of no association with
interaction, and TA was evaluated for each set of pseudo-samples.
After repeating this procedure 1000 times and ranking the 1000
TAs obtained, the threshold for TA at a 5% significance level can
be determined for the scenario under investigation. The power
was calculated by the proportion of the true models identified in
200 simulations with a TA larger than the threshold evaluated for
this scenario. The best model was identified on the maximization
of average TA and cross-validation consistency (CVC) according
to the principle of parsimony that the simplest model is preferred,
and the simpler interaction model was chosen if the two statistics
suggested different models. The permutation procedure was
similar for MDR to calculate the statistical power, except for
shuffling the phenotypic values instead of the residual scores
obtained with adjustment of the covariate in GMDR. Such a
protocol was commonly used in other reported power studies on
the MDR method [45,46].
The GMDR software was used to detect gene-gene interactions
under various scenarios. The default setting of parameters was
adopted in this study, and the GMDR software was also used to
conduct MDR algorithm by converting the status of each
individual to the corresponding score without covariate adjust-
ment.
Results
For comparison of the three models, their accuracies were
calculated by the aforementioned method (Table 1). The
heritability under each scenario was calculated, and the relations
between accuracy and heritability are plotted in Figure 3. Because
each interaction underlying a complex trait often contributes only
a small fraction to the overall heritability, the estimated heritability
for any single interaction is,0.05. In addition, there appears to be
a linear correlation between accuracy and heritability, with an r
Figure 2. Asymptotic trends of testing accuracy with different
sample sizes. The result was based on a checkerboard model whose
parameters were the same as shown in Figure 1. The solid lines are the
analytical accuracy and represent the upper bound of the testing
accuracy. The three lines downward are the means of the testing
accuracies from 200 simulations with a sample size of 2000, 1000, and
500. Because the lines for a sample size of.2000 are coincident with
the analytical accuracy lines, they are not shown.
doi:10.1371/journal.pone.0016981.g002
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models (Figure 3). If we excluded accuracies below 0.52, where
MAF=0.1, r increased for both 3ULM and 4ULM, especially for
the 3ULM model, with r increasing from 0.89 to 0.95 (Figure 3).
There were many G6G interactions detected underlying human
diseases (Figure S2, and Table S1), in which mostly the strength of
the interactions was measured by TA, rather than heritability.
When applying the linear correlation obtained from simulations to
the interactions detected by MDR and its extended methods, we
predict that the corresponding heritability for most detected gene-
gene interactions is between 0.01 and 0.05.
Generally speaking, for the three interaction models simulated,
the proportion of wrong models that were significant at the 5%
level was close to 0.05, as expected (data not shown). Furthermore,
most wrong models contained one or more functional loci, and
therefore, the wrong models could be treated as partially detected.
Figure 4 presents the powers of GMDR and MDR for the
checkerboard model. As shown, the GMDR had at least 80% for a
sample size of$1000, when the theoretical accuracy is around
0.56,0.62. This appears to be true for a sample of 500 when the
accuracy is.0.60. It is clear that the GMDR outperformed MDR
in most scenarios. This was attributed mainly to adjustment of the
covariate in the GMDR. However, such an advantage diminished
when the accuracy was.0.62, as both the GMDR and the MDR
methods showed almost full power. This was also true for a larger
sample (i.e., N.2000; data not shown).
Figures 5 and 6 show the powers for the 3ULM and 4ULM. As
shown in Table 1, because the accuracy is,0.52 when MAF=0.1,
the power results for those scenarios are less meaningful and thus
will not be presented. Similar to the results in the digenic model,
the GMDR outperformed MDR when the accuracy was between
0.56,0.62, and it was more apparent for 3ULM at sample sizes of
500 and 1000. For the GMDR, in order to yield a power greater
than 80% efficiently with accuracy at 0.56, a reasonable sample
size should be at least 2000 for trigenic and 4000 for tetragenic
models.
Discussion
Widespread but elusive multifactor interactions usually result in
a weak marginal correlation between a factor and the phenotype,
posing a significant challenge in identification of the risk factors for
complex diseases. Increasing effort is being expended to design
powerful detection methods. Although several promising methods
are available, the relevant issues of study design and data analysis
Figure 3. Linear correlation between accuracy and heritability. The solid line in each panel is fitted with the method of least squares, and its
r is shown in bold font. The dashed lines in 3ULM and 4ULM panels were fitted alike while excluding dots below 0.52, and their r values are shown
above the reference lines indicating accuracy of 0.52. For the six regression models, the p value for F test was,0.001.
doi:10.1371/journal.pone.0016981.g003
Table 1. Theoretical accuracies for the three simulated
models
a.
Model b MAF
0.1 0.25 0.5
Checkerboard 1.0 0.560 0.567 0.566
1.5 0.591 0.597 0.595
2.0 0.621 0.623 0.622
2.5 0.649 0.651 0.648
3ULM 1.0 0.505 0.536 0.562
1.5 0.508 0.557 0.593
2.0 0.511 0.578 0.623
2.5 0.515 0.602 0.652
4ULM 1.0 0.502 0.526 0.558
1.5 0.503 0.541 0.588
2.0 0.504 0.557 0.617
2.5 0.505 0.575 0.646
aAccuracies were calculated on the basis of the conditional genotypic
distribution or of the score distribution without adjustment. For each model,
three levels of MAFs and four genotype effects were employed. Hardy-
Weinberg and linkage equilibria were assumed.
doi:10.1371/journal.pone.0016981.t001
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power and the efficiency of statistical methods have not been well
explored. Here, we compared the statistical power and the
accuracy of two commonly used methods, MDR and GMDR
through theoretical computation and simulation studies under a
broad range of sample sizes and hypothetical parameter settings in
which the real parameters would potentially fall. The results
provide an empirical guideline for investigators to plan appropri-
ate studies.
In previous power studies of MDR [43,46,50], heritability was
commonly employed as an indicator parameter. As heritability
depends not only on genotypic penetrance and disease prevalence
but also on genotypic frequencies in a studied population, it is a
measure both of the population and of the gene effects — in other
words, heritability is a population-specific parameter even for the
same phenotype. Often, if not always, the original reference and
an ascertained population show differences in allele frequencies,
and heritability measured from the original population is not
sensitive in reflecting the property of an ascertained population
and vice versa. In case-control designs, thus, heritability is an
indicator parameter of less theoretical and practical value.
We believe that accuracy is a better metric to characterize the
connection between sample size and power in an interaction study.
First, in both GMDR and MDR, the classification accuracy and
TA are computed directly from the sample. Second, classification
accuracy and TA converge asymptotically to the theoretical
Figure 4. Power comparison of GMDR and MDR for sample sizes of 500, 1000, and 2000 under the checkerboard (digenic) model at
alpha=0.05. For each panel, 12 combinations, as defined in Table 1, were simulated, forming three levels of MAF (0.1, 0.25, and 0.5) and four levels
of interactive effects (1.0, 1.5, 2.0, and 2.5). Simulation results from sample sizes of 4000 and 10,000 are not shown because no difference in power
estimates were detected by the GMDR and MDR methods.
doi:10.1371/journal.pone.0016981.g004
Figure 5. Power comparison of GMDR and MDR for sample sizes of 500, 1000, 2000, and 4000 under the 3ULM (trigenic model) at
alpha=0.05. For each panel, 12 combinations, as defined in Table 1 were simulated, as shown here, which were formed of three levels of MAFs (0.1,
0.25, and 0.5) and four levels of interaction effects (1.0, 1.5, 2.0, and 2.5).
doi:10.1371/journal.pone.0016981.g005
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large sample. Third, accuracy is a straightforward and compre-
hensive measure of the strength of causality and the goodness of fit
of the model, through which other factors such as gene
frequencies, gene effects, heritability, and ascertainment conditions
influence statistical power. To gain a better understanding of
accuracy, we developed a general analytical method to compute
the mathematical expectation of accuracy, previously investigated
in silico, for a case-control sample. As an indicator statistic,
accuracy worked well in our simulations. It should be noticed that
balanced accuracy suggested by Velez et al [43] may be a better
metric to measure the fitness when the numbers of cases and
controls are unequal for the MDR method.
Furthermore, we found an empirical linear correlation between
accuracy and heritability in a wide range of circumstances given
different MAFs and penetrances under balanced case-control
designs. This will help find a connection between the previous
reports [7,11] and the present study. For the cases simulated and
under the sampling scheme investigated, accuracy ranging from
0.55,0.65 can be converted to a heritability of 0.01,0.05. This
implies that most of the interactions in the literature, the TAs of
which fell in this range (Figure S2), have a heritability of
0.01,0.05 with a sample size of 1000 to 2000. This correlation
provides an interpretation of genetic meaning for interactions
detected by GMDR and MDR, and probably is applicable to
interactions detected by other nonparametric statistics, such as
balanced testing accuracy [43].
In this study, we evaluated the statistical power of GMDR and
MDR using accuracy as an indicator to determine the sample sizes
required to provide sufficient testing power in a case-control
design. The GMDR with covariate adjustment could have a
power of.80% for an unrelated case-control design with a sample
size$2000, whereas the theoretical accuracy is around 0.56,0.62;
when the accuracy is,0.56 (heritability close to 0.01), a sample
size of at least 4000 would be required to provide sufficient power.
Generally speaking, when the sample size was 1000,2000,
GMDR appeared to outperform MDR for all simulated models
within the accuracy range, from 0.56 to 0.62, which was close to
the densely distributed region of TA in the published data (Figure
S2). As the sample size became larger, their difference became less
obvious. Large samples will become more common in the near
future, although most studies have a sample size of,2000. The
benefit of large samples in improving statistical power and
detecting interactions of much smaller effect sizes may be validated
in the future. As argued recently, however, tiny effects are
increasingly discovered in genome-wide association studies with
the help of enlarged samples, but whether tiny effects are of great
interest remains unclear [51,52]. Balancing the sample size and
the significance of the interaction detected deserves consideration,
such as in Figure S3, yet more data are needed to confirm that the
strength of interactions decreases in tandem with the sample size.
Although the above results were obtained entirely on the basis
of a case-control design, it can be introduced into the discordant
sib pair design because of their similarity in population structure.
For quantitative traits, as the process of gaining the mathematical
expectation of accuracy should be derived differently, it requires
an additional endeavor to reach similar conclusions and
consequently mandates further work. It seems difficult, although
probable, that in the future, interaction studies will move to the
genome-wide scale [53], and consequently the choice of
genotyping chips [41] and imputation approaches [54] should
be considered.
The GMDR software which was initially released in 2007 [14]
and now is available at http://www.ssg.uab.edu/gmdr.
Supporting Information
Figure S1 Six steps involved in data reduction algorithm.
(TIF)
Figure S2 A distribution of testing accuracy from the recently
reported literature on gene-gene interactions detected by the
MDR or GMDR approaches, with a mean of 0.606, SD of 0.047,
and range of 0.50 to 0.70 (Shapiro-Wilk test: p=0.8033). The
width of each bin is 0.02. A detailed list of these studies yielding
the values used in this study is provided in Table S1.
(TIF)
Figure S3 Scatter plot of reported gene-gene interactions with
respect to their testing accuracy and sample sizes. The vertical
lines partition the literature into four intervals with respect to their
Figure 6. Power comparison of GMDR and MDR for sample sizes of 500, 1000, 2000, and 4000 under the 4ULM (tetragenic model)
at alpha=0.05. For each panel, 12 combinations, as defined in Table 1, were simulated, as shown here, which were formed of three levels of MAFs
(0.1, 0.25, and 0.5) and four levels of interaction effects (1.0, 1.5, 2.0, and 2.5). Simulation results from the sample of 10,000 are not shown because no
difference in power estimates was detected for the GMDR and MDR methods.
doi:10.1371/journal.pone.0016981.g006
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PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e16981sample sizes: (0, 500), (500, 1000), (1000, 2000), and (2000, 4000).
The location of each black circle is determined by the means of
testing accuracy and sample size over the open spots within each
interval flanked by two neighboring vertical lines. Because of the
limited information available, the open circle for the sample size
of$4000 is not shown.
(TIF)
Table S1 Testing accuracy of human diseases detected with
GMDR/MDR methods in the recent literature.
(DOC)
Text S1 Conditional genotype distribution of the checkerboard
model.
(DOC)
Text S2 The expectation of the residual score for a subject.
(DOC)
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